ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2263

Differentiated Phenotypes at Diagnosis of Sarcoidosis According to the Scadding Classification: Analysis in 1230 Patients

Soledad Retamozo1,2,3, Roberto Pérez-Alvarez4, Pilar Brito-Zerón5,6, Belchin Kostov7, Carlos Feijoo Massó8, Guadalupe Fraile9, A. González-García10, Ricardo Gómez De La Torre11, Begoña De-Escalante12, Miguel Lopez-Dupla13, Ana Alguacil14, Joel Chara-Cervantes15, M. Pérez-Conesa16, Francisco-Javier Rascón17, Jose Salvador Garcia Morillo18, Patricia Perez Guerrero19, Eva Fonseca Aizpuru20, Miriam Akasbi21, Mariona Bonet22, José Luis Callejas23, Gloria De La Red Bellvis24, Eva Calvo Begueria25, Cristina Soler i Ferrer26, Enrique Peral Gutiérrez De Ceballos27, J. F. Gómez-Cerezo28, Gracia Cruz Caparrós29, Sergio Rodríguez Fernández30, Blanca Pinilla31, Alberto Gato Diez32, A. Rolo33, César Morcillo6, Angel Robles34, Inmaculada Ojeda35, M. J. Vives36, Borja de-Miguel37, María Penadés Vidal38, Moisés De Vicente39, Xavier Bosh40, Marta Pérez-de-Lis41, A. González-García9, Carmen Yllera Gutiérrez42, B. Gracia-Tello43, M. Pedrosa44, A. Perez-Gonzalez4, Carles Tolosa45, Antoni Sisó-Almirall46, Lucio Pallarés47 and Manuel Ramos-Casals5, 1Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Córdoba, Consejo Nacional de Investigaciones Científicas y Técnicas (INICSA-UNC-CONICET), Cordoba, Argentina, 2Laboratory of Systemic Autoimmune Diseases “Josep Font”, CELLEX, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Systemic Autoimmune Diseases, ICMID, Hospital Clinic, Barcelona, Barcelona, Spain, 3Rheumatology Unit, Hospital Privado Universitario de Córdoba, Institute University of Biomedical Sciences University of Córdoba (IUCBC), Cordoba, Argentina, 4Department of Internal Medicine, Hospital Alvaro Cunqueiro, Vigo, Vigo, Spain, 5Laboratory of Autoimmune Diseases Josep Font, IDIBAPS, Department of Autoimmune Diseases, ICMiD, Hospital Clinic, Barcelona, Barcelona, Spain, 6Systemic Autoimmune Diseases Unit, Hospital CIMA-Sanitas, Barcelona, Barcelona, Spain, 7Primary Care Research Group, IDIBAPS, Centre d’Assistència Primària ABS Les Corts, GESCLINIC, Barcelona, Barcelona, Spain, 8Department of Internal Medicine, Hospital Parc Taulí, Sabadell, Sadabell, Spain, 9Hospital Ramon y Cajal, Madrid, Madrid, Spain, 10Internal Medicine, Hospital Ramón y Cajal, Madrid, Madrid, Spain, 11Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Oviedo, Spain, 12Hospital Clínico, Zaragoza, Zaragoza, Spain, 13Systemic Autoimmune Diseases Unit, Hospital Joan XXIII, Tarragona, Tarragona, Spain, 14Hospital Virgen de la Salud, Toledo, Toledo, Spain, 15Hospital Universitario Miguel Servet, Zaragoza, Zaragoza, Spain, 16Hospital Miguel Servet, Zaragoza, Zaragoza, Spain, 17Hospital Son Espases, Palma de Mallorca, Palma de Mallorca, Spain, 18Department of Internal Medicine, Hospital Virgen del Rocio, Sevilla, Sevilla, Spain, 19Department of Internal Medicine, Hospital Universitario Puerta del Mar, Cádiz, Cadiz, Spain, 20Department of Internal Medicine, Hospital de Cabueñes, Gijón, Gijón, Spain, 21Department of Internal Medicine, Hospital Infanta Leonor, Madrid, Madrid, Spain, 22Department of Internal Medicine, Althaia, Xarxa Assistencial de Manresa, Manresa, Spain, 23Hospital Clínico San Cecilio, Granada, Granada, Spain, 24Department of Internal Medicine, Hospital de Santa Coloma de Gramanet, Barcelona, Barcelona, Spain, 25Hospital Universitario Puerta del Mar, Cádiz, Cádiz, Spain, 26Hospital de Sta Caterina, Girona, Girona, Spain, 27Department of Internal Medicine, Hospital Virgen Macarena, Sevilla, Sevilla, Spain, 28Hospital Infanta Sofía, Madrid, Madrid, Spain, 29Department of Internal Medicine, Hospital de Poniente El Ejido, Almería, Almería, Spain, 30Department of Internal Medicine, Hospital da Barbanza, A Coruña, A Coruña, Spain, 31Systemic Autoimmune Diseases Unit Medicine, Hospital Gregorio Marañón, Madrid, Madrid, Spain, 32Department of Internal Medicine, Complejo Hospitalario Albacete, Albacete, Albacete, Spain, 33Hospital Salamanca, Salamanca, Salamanca, Spain, 34Hospital La Paz, Madrid, Madrid, Spain, 35Department of Internal Medicine, Hospital Valle del Guadiato, Córdoba, Cordoba, Spain, 36Parc Sanitari San Joan de Déu, Sant Boi, Barcelona, Spain, 37Hospital 12 de Octubre, Madrid, Madrid, Spain, 38Department of Internal Medicine, Hospital De Manises, Valencia, Valencia, Spain, 39Department of Internal Medicine, Hospital Nuestra Señora del Prado, Talavera, Talavera, Spain, 40Department of Internal Medicine, ICMiD, Hospital Clinic, Barcelona, Barcelona, Spain, 41Servicio de Anestesiologia y Reanimación. Complejo Hospitalario Universitario de A Coruña, A Coruña, A Coruña, Spain, 42Hospital Universitario Central de Asturias, Oviedo, Oviedo, Spain, 43Hospital Clinico, Zaragoza, Zaragoza, Spain, 44Hospìtal Parc Taulí, Sadabell, Sabadell, Spain, 45Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Barcelona, Spain, 46Grup de Recerca Transversal en Atenció Primària, IDIBAPS, Barcelona, Barcelona, Spain, 47Department of Internal Medicine, Hospital Son Espases. Palma de Mallorca, Palma de Mallorca, Spain

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Phenotypes and sarcoidosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Miscellaneous Rheumatic and Inflammatory Diseases Poster III: Sarcoid, Inflammatory Eye Disease, and Autoinflammatory Disease

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: To analyse the correlation between Scadding radiological stages and the main phenotypic features at diagnosis (epidemiology, clinical patterns at presentation, extrathoracic disease and need for initial systemic therapy) in one of the largest cohorts of patients with sarcoidosis reported from Southern Europe.

Methods: The SARCOGEAS-Study Group was formed in 2015 including a multicenter database of consecutive patients diagnosed with sarcoidosis according to the WASOG 1999 criteria. Extrathoracic disease at diagnosis was defined according to the 2014 WASOG organ assessment instrument and the extrathoracic clusters proposed by Schupp et al.

Results: 1230 patients were finally analysed (712 women, mean age 47.3 yrs). Scadding radiologic stage at diagnosis consisted of stage 0 in 98 (8%) patients, stage I in 395 (32%), stage II in 500 (41%), stage III in 195 (16%) and stage IV in 42 (3%) patients. Epidemiologically, age at diagnosis was clearly linked with the Scadding stage, with younger mean ages being reported for stages I and II (p=0.001). With respect to extrathoracic disease, the highest frequencies of the organ-by-organ WASOG involvements are reported in stage 0 (skin, liver, spleen, ENT, nervous system and bone marrow), stage I (salivary glands, bone/joint) and stage IV (extra-thoracic lymph node, eye, kidney, calcium-vitamin D and heart) (FIGURE 1). The three SchappÕs extrathoracic clusters are overrepresented in stage 0. Patients with stage IV had the highest frequencies of both need of and aggressiveness of therapy, while patients with stage I had the lowest frequencies. Pulmonary fibrosis was related to a higher mean age at diagnosis (55 vs 47 yrs, p<0.001), a higher mean number of extrathoracic organs involved (1.5 vs 1.1, p=0.045), a higher frequency of calcium/vitamin D WASOG involvement (17% vs 7%, p=0.047) and a higher frequency of need for therapy (81% vs 49%, p<0.001); no statistically-significant differences were found between the stages II and III.

Conclusion: We found a significant association between Scadding stages and sarcoidosis phenotype at the time of diagnosis, including epidemiological profile, extrathoracic involvement and initial therapeutic management. However, the key determinant in phenotyping the disease at diagnosis was the involvement of each organ more than the classification using the Scadding stages.


Figure 1.


Disclosure: S. Retamozo, None; R. Pérez-Alvarez, None; P. Brito-Zerón, None; B. Kostov, None; C. Feijoo Massó, None; G. Fraile, None; A. González-García, None; R. Gómez De La Torre, None; B. De-Escalante, None; M. Lopez-Dupla, None; A. Alguacil, None; J. Chara-Cervantes, None; M. Pérez-Conesa, None; F. J. Rascón, None; J. S. Garcia Morillo, None; P. Perez Guerrero, None; E. Fonseca Aizpuru, None; M. Akasbi, None; M. Bonet, None; J. L. Callejas, None; G. De La Red Bellvis, None; E. Calvo Begueria, None; C. Soler i Ferrer, None; E. Peral Gutiérrez De Ceballos, None; J. F. Gómez-Cerezo, None; G. Cruz Caparrós, None; S. Rodríguez Fernández, None; B. Pinilla, None; A. Gato Diez, None; A. Rolo, None; C. Morcillo, None; A. Robles, None; I. Ojeda, None; M. J. Vives, None; B. de-Miguel, None; M. Penadés Vidal, None; M. De Vicente, None; X. Bosh, None; M. Pérez-de-Lis, None; A. González-García, None; C. Yllera Gutiérrez, None; B. Gracia-Tello, None; M. Pedrosa, None; A. Perez-Gonzalez, None; C. Tolosa, None; A. Sisó-Almirall, None; L. Pallarés, None; M. Ramos-Casals, None.

To cite this abstract in AMA style:

Retamozo S, Pérez-Alvarez R, Brito-Zerón P, Kostov B, Feijoo Massó C, Fraile G, González-García A, Gómez De La Torre R, De-Escalante B, Lopez-Dupla M, Alguacil A, Chara-Cervantes J, Pérez-Conesa M, Rascón FJ, Garcia Morillo JS, Perez Guerrero P, Fonseca Aizpuru E, Akasbi M, Bonet M, Callejas JL, De La Red Bellvis G, Calvo Begueria E, Soler i Ferrer C, Peral Gutiérrez De Ceballos E, Gómez-Cerezo JF, Cruz Caparrós G, Rodríguez Fernández S, Pinilla B, Gato Diez A, Rolo A, Morcillo C, Robles A, Ojeda I, Vives MJ, de-Miguel B, Penadés Vidal M, De Vicente M, Bosh X, Pérez-de-Lis M, González-García A, Yllera Gutiérrez C, Gracia-Tello B, Pedrosa M, Perez-Gonzalez A, Tolosa C, Sisó-Almirall A, Pallarés L, Ramos-Casals M. Differentiated Phenotypes at Diagnosis of Sarcoidosis According to the Scadding Classification: Analysis in 1230 Patients [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/differentiated-phenotypes-at-diagnosis-of-sarcoidosis-according-to-the-scadding-classification-analysis-in-1230-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/differentiated-phenotypes-at-diagnosis-of-sarcoidosis-according-to-the-scadding-classification-analysis-in-1230-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology